Shanghai Entry-exit Inspection and Quarantine Bureau has launched a series of measures for the newly established bio-pharmaceutical scientific innovation center to effectively monitor the import and export of experimental animals and plants，according to a news report published on Pudong's official website on Jan 3.

The measures are significant in boosting the development of biological medicine industries in Shanghai's free trade zone.

Shanghai Free Trade Zone International Bio-pharmaceutical Scientific Innovation Center was established on Dec 26, 2017. It is the first large-scale biological medicine platform in the zone and will develop into an international one which incorporates financing, equity transaction, and project incubation.

The department will take some relevant measures to import specific pathogen free (SPF) laboratory animals.

Additionally, the department will relax the quarantine requirements on the animals that come into the center, with scientists being allowed to do experiments on these animals during their 30-day quarantine. This policy will help to reduce the time spent undertaking the experiments.

Meanwhile, the registration of experimental animals for exports has been cancelled, meaning that the technical barriers to trade will be removed.  

Barriers of the import of the fodder which is prepared specially for the experimental animals will also be lowered. This will mean the fodder for the experimental animals will be exempt from examination as long as its use is put under the scrutiny of the Inspection and Quarantine Bureau. This policy will also help to reduce the time spent undertaking the experiments, by seven to 10 days.

Moreover, the bureau will try to further simplify the procedures for examination and approval to facilitate imports and exports.

The bureau will also take some other protective measures when the center is confronted with problems which hinder scientific research and production.

Bio-pharmaceutical scientific innovation center. [Photo/ chinatradenews.com.cn]